-
1
-
-
77950611229
-
Institute of Medicine recommendations for the prevention and control of hepatitis B and C
-
A.E. Mitchell, H.M. Colvin, R. Palmer Beasley Institute of Medicine recommendations for the prevention and control of hepatitis B and C Hepatology 51 2010 729 733
-
(2010)
Hepatology
, vol.51
, pp. 729-733
-
-
Mitchell, A.E.1
Colvin, H.M.2
Palmer Beasley, R.3
-
2
-
-
80051688850
-
The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference
-
A. Hatzakis, S. Wait, J. Bruix The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference J Viral Hepat 18 Suppl 1 2011 1 16
-
(2011)
J Viral Hepat
, vol.18
, Issue.SUPPL. 1
, pp. 1-16
-
-
Hatzakis, A.1
Wait, S.2
Bruix, J.3
-
3
-
-
33748338297
-
Hepatitis B vaccines
-
World Health Organization
-
World Health Organization Hepatitis B vaccines Wkly Epidemiol Rec 79 2004 253 264
-
(2004)
Wkly Epidemiol Rec
, vol.79
, pp. 253-264
-
-
-
4
-
-
33748114343
-
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
-
J.F. Perz, G.L. Armstrong, L.A. Farrington The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
-
(2006)
J Hepatol
, vol.45
, pp. 529-538
-
-
Perz, J.F.1
Armstrong, G.L.2
Farrington, L.A.3
-
5
-
-
79952220557
-
Hepatitis B virus in the United States: Infection, exposure, and immunity rates in a nationally representative survey
-
G.N. Ioannou Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey Ann Intern Med 154 2011 319 328
-
(2011)
Ann Intern Med
, vol.154
, pp. 319-328
-
-
Ioannou, G.N.1
-
6
-
-
33646492332
-
Screening for chronic hepatitis B among Asian/Pacific islander populations-New York City, 2005
-
CDC
-
CDC Screening for chronic hepatitis B among Asian/Pacific islander populations-New York City, 2005 Morb Mortal Wkly Rep 55 2006 505 509
-
(2006)
Morb Mortal Wkly Rep
, vol.55
, pp. 505-509
-
-
-
7
-
-
21244447705
-
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
-
G.K. Lau, T. Piratvisuth, K.X. Luo Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 352 2005 2682 2695
-
(2005)
N Engl J Med
, vol.352
, pp. 2682-2695
-
-
Lau, G.K.1
Piratvisuth, T.2
Luo, K.X.3
-
8
-
-
4544239807
-
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
-
P. Marcellin, G.K. Lau, F. Bonino Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
-
(2004)
N Engl J Med
, vol.351
, pp. 1206-1217
-
-
Marcellin, P.1
Lau, G.K.2
Bonino, F.3
-
9
-
-
19944428132
-
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial
-
H.L. Janssen, M. van Zonneveld, H. Senturk Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 365 2005 123 129
-
(2005)
Lancet
, vol.365
, pp. 123-129
-
-
Janssen, H.L.1
Van Zonneveld, M.2
Senturk, H.3
-
10
-
-
13444309139
-
A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone
-
H.L. Chan, N.W. Leung, A.Y. Hui A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone Ann Intern Med 142 2005 240 250
-
(2005)
Ann Intern Med
, vol.142
, pp. 240-250
-
-
Chan, H.L.1
Leung, N.W.2
Hui, A.Y.3
-
11
-
-
0033592764
-
Lamivudine as initial treatment for chronic hepatitis B in the United States
-
J.L. Dienstag, E.R. Schiff, T.L. Wright Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256 1263
-
(1999)
N Engl J Med
, vol.341
, pp. 1256-1263
-
-
Dienstag, J.L.1
Schiff, E.R.2
Wright, T.L.3
-
12
-
-
0037468421
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
-
P. Marcellin, T.T. Chang, S.G. Lim Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816
-
(2003)
N Engl J Med
, vol.348
, pp. 808-816
-
-
Marcellin, P.1
Chang, T.T.2
Lim, S.G.3
-
13
-
-
21244455293
-
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
-
S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B N Engl J Med 352 2005 2673 2681
-
(2005)
N Engl J Med
, vol.352
, pp. 2673-2681
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
-
14
-
-
37349120537
-
Telbivudine versus lamivudine in patients with chronic hepatitis B
-
C.L. Lai, E. Gane, Y.F. Liaw Telbivudine versus lamivudine in patients with chronic hepatitis B N Engl J Med 357 2007 2576 2588
-
(2007)
N Engl J Med
, vol.357
, pp. 2576-2588
-
-
Lai, C.L.1
Gane, E.2
Liaw, Y.F.3
-
15
-
-
33644822860
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
-
C.L. Lai, D. Shouval, A.S. Lok Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B N Engl J Med 354 2006 1011 1020
-
(2006)
N Engl J Med
, vol.354
, pp. 1011-1020
-
-
Lai, C.L.1
Shouval, D.2
Lok, A.S.3
-
16
-
-
33644818518
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
-
T.T. Chang, R.G. Gish, R. de Man A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B N Engl J Med 354 2006 1001 1010
-
(2006)
N Engl J Med
, vol.354
, pp. 1001-1010
-
-
Chang, T.T.1
Gish, R.G.2
De Man, R.3
-
17
-
-
57349095400
-
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
-
P. Marcellin, E.J. Heathcote, M. Buti Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B N Engl J Med 359 2008 2442 2455
-
(2008)
N Engl J Med
, vol.359
, pp. 2442-2455
-
-
Marcellin, P.1
Heathcote, E.J.2
Buti, M.3
-
18
-
-
48549107919
-
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b
-
E.H. Buster, H.J. Flink, Y. Cakaloglu Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b Gastroenterology 135 2008 459 467
-
(2008)
Gastroenterology
, vol.135
, pp. 459-467
-
-
Buster, E.H.1
Flink, H.J.2
Cakaloglu, Y.3
-
19
-
-
77952725714
-
Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
-
V.W. Wong, G.L. Wong, K.K. Yan Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 1945 1953
-
(2010)
Hepatology
, vol.51
, pp. 1945-1953
-
-
Wong, V.W.1
Wong, G.L.2
Yan, K.K.3
-
20
-
-
66449121130
-
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a
-
e1-4
-
P. Marcellin, F. Bonino, G.K. Lau Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a Gastroenterology 136 2009 2169 2179 e1-4
-
(2009)
Gastroenterology
, vol.136
, pp. 2169-2179
-
-
Marcellin, P.1
Bonino, F.2
Lau, G.K.3
-
21
-
-
33745921497
-
A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B
-
M. Zeng, Y. Mao, G. Yao A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B Hepatology 44 2006 108 116
-
(2006)
Hepatology
, vol.44
, pp. 108-116
-
-
Zeng, M.1
Mao, Y.2
Yao, G.3
-
22
-
-
84860315818
-
Long-term telbivudine therapy with effective viral control results in resolution of liver fibrosis and inflammation achieving treatment goals in patients with chronic hepatitis B (abstr)
-
J.L. Hou, D.Z. Xu, S. Guangeng Long-term telbivudine therapy with effective viral control results in resolution of liver fibrosis and inflammation achieving treatment goals in patients with chronic hepatitis B (abstr) Hepatology Suppl 2011 1048A
-
(2011)
Hepatology
, Issue.SUPPL.
-
-
Hou, J.L.1
Xu, D.Z.2
Guangeng, S.3
-
23
-
-
10744225554
-
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
-
A.S. Lok, C.L. Lai, N. Leung Long-term safety of lamivudine treatment in patients with chronic hepatitis B Gastroenterology 125 2003 1714 1722
-
(2003)
Gastroenterology
, vol.125
, pp. 1714-1722
-
-
Lok, A.S.1
Lai, C.L.2
Leung, N.3
-
24
-
-
51349107091
-
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
-
P. Marcellin, T.T. Chang, S.G. Lim Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B Hepatology 48 2008 750 758
-
(2008)
Hepatology
, vol.48
, pp. 750-758
-
-
Marcellin, P.1
Chang, T.T.2
Lim, S.G.3
-
25
-
-
79953311247
-
Long term (4 year) efficacy and safety of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients (HBeAg+) with chronic hepatitis B (study 103)
-
J. Heathcote Long term (4 year) efficacy and safety of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients (HBeAg+) with chronic hepatitis B (study 103) Hepatology 52 Suppl 2010 556A 557A
-
(2010)
Hepatology
, vol.52
, Issue.SUPPL.
-
-
Heathcote, J.1
-
26
-
-
77955485392
-
Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B
-
J.G. Reijnders, M.J. Perquin, N. Zhang Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B Gastroenterology 139 2010 491 498
-
(2010)
Gastroenterology
, vol.139
, pp. 491-498
-
-
Reijnders, J.G.1
Perquin, M.J.2
Zhang, N.3
-
27
-
-
75449093009
-
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
-
H.W. Lee, H.J. Lee, J.S. Hwang Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B Hepatology 51 2010 415 421
-
(2010)
Hepatology
, vol.51
, pp. 415-421
-
-
Lee, H.W.1
Lee, H.J.2
Hwang, J.S.3
-
28
-
-
0037468406
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
-
S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 2003 800 807
-
(2003)
N Engl J Med
, vol.348
, pp. 800-807
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
-
29
-
-
33845671388
-
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
-
S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 2006 1743 1751
-
(2006)
Gastroenterology
, vol.131
, pp. 1743-1751
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
-
30
-
-
0032499913
-
A one-year trial of lamivudine for chronic hepatitis B Asia Hepatitis Lamivudine Study Group
-
C.L. Lai, R.N. Chien, N.W. Leung A one-year trial of lamivudine for chronic hepatitis B Asia Hepatitis Lamivudine Study Group N Engl J Med 339 1998 61 68
-
(1998)
N Engl J Med
, vol.339
, pp. 61-68
-
-
Lai, C.L.1
Chien, R.N.2
Leung, N.W.3
-
31
-
-
70350089249
-
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States
-
W.R. Kim, N.A. Terrault, R.A. Pedersen Trends in waiting list registration for liver transplantation for viral hepatitis in the United States Gastroenterology 137 2009 1680 1686
-
(2009)
Gastroenterology
, vol.137
, pp. 1680-1686
-
-
Kim, W.R.1
Terrault, N.A.2
Pedersen, R.A.3
-
32
-
-
33751514752
-
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
-
S.M. Lin, M.L. Yu, C.M. Lee Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma J Hepatol 46 2007 45 52
-
(2007)
J Hepatol
, vol.46
, pp. 45-52
-
-
Lin, S.M.1
Yu, M.L.2
Lee, C.M.3
-
33
-
-
0029893146
-
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
-
C. Niederau, T. Heintges, S. Lange Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B N Engl J Med 334 1996 1422 1427
-
(1996)
N Engl J Med
, vol.334
, pp. 1422-1427
-
-
Niederau, C.1
Heintges, T.2
Lange, S.3
-
34
-
-
61449187479
-
Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: A meta-analysis
-
Y.F. Yang, W. Zhao, Y.D. Zhong Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis J Viral Hepat 16 2009 265 271
-
(2009)
J Viral Hepat
, vol.16
, pp. 265-271
-
-
Yang, Y.F.1
Zhao, W.2
Zhong, Y.D.3
-
35
-
-
53549107488
-
Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
-
J.J. Sung, K.K. Tsoi, V.W. Wong Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 2008 1067 1077
-
(2008)
Aliment Pharmacol Ther
, vol.28
, pp. 1067-1077
-
-
Sung, J.J.1
Tsoi, K.K.2
Wong, V.W.3
-
36
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
Y.F. Liaw, J.J. Sung, W.C. Chow Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
-
(2004)
N Engl J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
-
37
-
-
77955306935
-
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
-
G.V. Papatheodoridis, P. Lampertico, S. Manolakopoulos Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review J Hepatol 53 2010 348 356
-
(2010)
J Hepatol
, vol.53
, pp. 348-356
-
-
Papatheodoridis, G.V.1
Lampertico, P.2
Manolakopoulos, S.3
-
39
-
-
77956639159
-
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
-
T.T. Chang, Y.F. Liaw, S.S. Wu Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
-
(2010)
Hepatology
, vol.52
, pp. 886-893
-
-
Chang, T.T.1
Liaw, Y.F.2
Wu, S.S.3
-
40
-
-
34247538953
-
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
-
F. Bonino, P. Marcellin, G.K. Lau Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B Gut 56 2007 699 705
-
(2007)
Gut
, vol.56
, pp. 699-705
-
-
Bonino, F.1
Marcellin, P.2
Lau, G.K.3
-
41
-
-
80054724912
-
Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
-
H.L. Chan, A. Thompson, M. Martinot-Peignoux Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report J Hepatol 55 2011 1121 1131
-
(2011)
J Hepatol
, vol.55
, pp. 1121-1131
-
-
Chan, H.L.1
Thompson, A.2
Martinot-Peignoux, M.3
-
42
-
-
0032869876
-
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Asian Hepatitis Lamivudine Trial Group
-
R.N. Chien, Y.F. Liaw, M. Atkins Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Asian Hepatitis Lamivudine Trial Group Hepatology 30 1999 770 774
-
(1999)
Hepatology
, vol.30
, pp. 770-774
-
-
Chien, R.N.1
Liaw, Y.F.2
Atkins, M.3
-
43
-
-
58649096155
-
2-Year GLOBE trial results: Telbivudine is superior to lamivudine in patients with chronic hepatitis B
-
Y.F. Liaw, E. Gane, N. Leung 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B Gastroenterology 136 2009 486 495
-
(2009)
Gastroenterology
, vol.136
, pp. 486-495
-
-
Liaw, Y.F.1
Gane, E.2
Leung, N.3
-
44
-
-
73149085984
-
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
-
C.M. Lange, J. Bojunga, W.P. Hofmann Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function Hepatology 50 2009 2001 2006
-
(2009)
Hepatology
, vol.50
, pp. 2001-2006
-
-
Lange, C.M.1
Bojunga, J.2
Hofmann, W.P.3
-
45
-
-
79959551969
-
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
-
Y.F. Liaw, M. Raptopoulou-Gigi, H. Cheinquer Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study Hepatology 54 2011 91 100
-
(2011)
Hepatology
, vol.54
, pp. 91-100
-
-
Liaw, Y.F.1
Raptopoulou-Gigi, M.2
Cheinquer, H.3
-
46
-
-
78751491184
-
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
-
Y.F. Liaw, I.S. Sheen, C.M. Lee Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease Hepatology 53 2011 62 72
-
(2011)
Hepatology
, vol.53
, pp. 62-72
-
-
Liaw, Y.F.1
Sheen, I.S.2
Lee, C.M.3
-
47
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
A.S. Lok, B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
48
-
-
51049107683
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
-
Y.F. Liaw, N. Leung, J.H. Kao Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
-
(2008)
Hepatol Int
, vol.2
, pp. 263-283
-
-
Liaw, Y.F.1
Leung, N.2
Kao, J.H.3
-
49
-
-
58149296156
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
-
(2009)
J Hepatol
, vol.50
, pp. 227-242
-
-
-
50
-
-
33644858331
-
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
-
U.H. Iloeje, H.I. Yang, J. Su Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 2006 678 686
-
(2006)
Gastroenterology
, vol.130
, pp. 678-686
-
-
Iloeje, U.H.1
Yang, H.I.2
Su, J.3
-
51
-
-
13844322073
-
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
-
M.W. Yu, S.H. Yeh, P.J. Chen Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men J Natl Cancer Inst 97 2005 265 272
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 265-272
-
-
Yu, M.W.1
Yeh, S.H.2
Chen, P.J.3
-
52
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
C.J. Chen, H.I. Yang, J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
-
53
-
-
80053577592
-
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
-
e2
-
C.F. Chen, W.C. Lee, H.I. Yang Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma Gastroenterology 141 2011 1240 1248 e2
-
(2011)
Gastroenterology
, vol.141
, pp. 1240-1248
-
-
Chen, C.F.1
Lee, W.C.2
Yang, H.I.3
-
54
-
-
34247478067
-
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: Histologic findings and outcome
-
T. Andreani, L. Serfaty, D. Mohand Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome Clin Gastroenterol Hepatol 5 2007 636 641
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 636-641
-
-
Andreani, T.1
Serfaty, L.2
Mohand, D.3
-
55
-
-
34548303664
-
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
-
C.K. Hui, N. Leung, S.T. Yuen Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase Hepatology 46 2007 395 401
-
(2007)
Hepatology
, vol.46
, pp. 395-401
-
-
Hui, C.K.1
Leung, N.2
Yuen, S.T.3
-
56
-
-
55549091704
-
The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: Association with liver disease progression A prospective cohort study
-
G. Zacharakis, J. Koskinas, S. Kotsiou The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression A prospective cohort study J Hepatol 49 2008 884 891
-
(2008)
J Hepatol
, vol.49
, pp. 884-891
-
-
Zacharakis, G.1
Koskinas, J.2
Kotsiou, S.3
-
57
-
-
0036110833
-
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
-
M. Martinot-Peignoux, N. Boyer, M. Colombat Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers J Hepatol 36 2002 543 546
-
(2002)
J Hepatol
, vol.36
, pp. 543-546
-
-
Martinot-Peignoux, M.1
Boyer, N.2
Colombat, M.3
-
58
-
-
70649104668
-
Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa
-
E.H. Buster, B.E. Hansen, G.K. Lau Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa Gastroenterology 137 2009 2002 2009
-
(2009)
Gastroenterology
, vol.137
, pp. 2002-2009
-
-
Buster, E.H.1
Hansen, B.E.2
Lau, G.K.3
-
59
-
-
77950609092
-
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
-
I.C. Wu, C.L. Lai, S.H. Han Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage Hepatology 51 2010 1185 1189
-
(2010)
Hepatology
, vol.51
, pp. 1185-1189
-
-
Wu, I.C.1
Lai, C.L.2
Han, S.H.3
-
60
-
-
34447259615
-
The natural history and treatment of chronic hepatitis B: A critical evaluation of standard treatment criteria and end points
-
C.L. Lai, M.F. Yuen The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points Ann Intern Med 147 2007 58 61
-
(2007)
Ann Intern Med
, vol.147
, pp. 58-61
-
-
Lai, C.L.1
Yuen, M.F.2
-
61
-
-
84860292208
-
The efficacy and tolerability of pegylated interferon-alpha-2a in chronic hepatitis B: A multicenter clinical experience
-
[Epub ahead of print]
-
D. Ratnam, A. Dev, T. Nguyen The efficacy and tolerability of pegylated interferon-alpha-2a in chronic hepatitis B: a multicenter clinical experience J Gastroenterol Hepatol 2011 Dec 14 [Epub ahead of print]
-
(2011)
J Gastroenterol Hepatol
-
-
Ratnam, D.1
Dev, A.2
Nguyen, T.3
-
62
-
-
84863011075
-
A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice
-
M.C. Tsai, C.M. Lee, K.W. Chiu A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice J Antimicrob Chemother 67 2012 696 699
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 696-699
-
-
Tsai, M.C.1
Lee, C.M.2
Chiu, K.W.3
-
63
-
-
78649631236
-
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
-
W. Chotiyaputta, C. Peterson, F.A. Ditah Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B J Hepatol 54 2011 12 18
-
(2011)
J Hepatol
, vol.54
, pp. 12-18
-
-
Chotiyaputta, W.1
Peterson, C.2
Ditah, F.A.3
-
64
-
-
79957481330
-
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
-
C. Hongthanakorn, W. Chotiyaputta, K. Oberhelman Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice Hepatology 53 2011 1854 1863
-
(2011)
Hepatology
, vol.53
, pp. 1854-1863
-
-
Hongthanakorn, C.1
Chotiyaputta, W.2
Oberhelman, K.3
-
65
-
-
34547810965
-
Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California
-
C.A. Wu, S.Y. Lin, S.K. So Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California Asian Pac J Cancer Prev 8 2007 127 134
-
(2007)
Asian Pac J Cancer Prev
, vol.8
, pp. 127-134
-
-
Wu, C.A.1
Lin, S.Y.2
So, S.K.3
-
66
-
-
33947512072
-
Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans
-
G.X. Ma, S.E. Shive, C.Y. Fang Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans J Health Care Poor Underserved 18 2007 62 73
-
(2007)
J Health Care Poor Underserved
, vol.18
, pp. 62-73
-
-
Ma, G.X.1
Shive, S.E.2
Fang, C.Y.3
-
67
-
-
33847781872
-
Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants
-
G.X. Ma, C.Y. Fang, S.E. Shive Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants J Immigr Minor Health 9 2007 213 220
-
(2007)
J Immigr Minor Health
, vol.9
, pp. 213-220
-
-
Ma, G.X.1
Fang, C.Y.2
Shive, S.E.3
-
68
-
-
79955417384
-
Management of chronic hepatitis B virus (HBV) infection by primary care physicians in urban hospital and clinics in New York City
-
[abstract 984]
-
H. Pollack, K. Wan, T. Miyoshi Management of chronic hepatitis B virus (HBV) infection by primary care physicians in urban hospital and clinics in New York City Hepatology 46 Suppl 2007 676A [abstract 984]
-
(2007)
Hepatology
, vol.46
, Issue.SUPPL.
-
-
Pollack, H.1
Wan, K.2
Miyoshi, T.3
-
69
-
-
67449151609
-
The Jade Ribbon Campaign: A model program for community outreach and education to prevent liver cancer in Asian Americans
-
S.D. Chao, E.T. Chang, P.V. Le The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans J Immigr Minor Health 11 2009 281 290
-
(2009)
J Immigr Minor Health
, vol.11
, pp. 281-290
-
-
Chao, S.D.1
Chang, E.T.2
Le, P.V.3
-
70
-
-
79955414239
-
Are primary care clinicians knowledgeable about screening for chronic hepatitis B infection?
-
Presented at the 30th annual meeting of the Society of General Internal Medicine (SGIM)
-
M. Dulay, A. Baron, C. Lai Are primary care clinicians knowledgeable about screening for chronic hepatitis B infection? Presented at the 30th annual meeting of the Society of General Internal Medicine (SGIM) J Gen Intern Med 22 Suppl 1 2007 747 753
-
(2007)
J Gen Intern Med
, vol.22
, Issue.SUPPL. 1
, pp. 747-753
-
-
Dulay, M.1
Baron, A.2
Lai, C.3
-
71
-
-
43549097763
-
Family physicians' knowledge and screening of chronic hepatitis and liver cancer
-
J.M. Ferrante, D.G. Winston, P.H. Chen Family physicians' knowledge and screening of chronic hepatitis and liver cancer Fam Med 40 2008 345 351
-
(2008)
Fam Med
, vol.40
, pp. 345-351
-
-
Ferrante, J.M.1
Winston, D.G.2
Chen, P.H.3
-
72
-
-
79955461172
-
Is chronic hepatitis B being undertreated in the United States?
-
C. Cohen, S.D. Holmberg, B.J. McMahon Is chronic hepatitis B being undertreated in the United States? J Viral Hepat 18 2011 377 383
-
(2011)
J Viral Hepat
, vol.18
, pp. 377-383
-
-
Cohen, C.1
Holmberg, S.D.2
McMahon, B.J.3
-
73
-
-
80053465684
-
Treatment of chronic hepatitis B virus infection in resource-constrained settings: Expert panel consensus
-
S.T. Wiersma, B. McMahon, J.M. Pawlotsky Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus Liver Int 31 2011 755 761
-
(2011)
Liver Int
, vol.31
, pp. 755-761
-
-
Wiersma, S.T.1
McMahon, B.2
Pawlotsky, J.M.3
-
74
-
-
0042265556
-
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
-
C.T. Wai, J.K. Greenson, R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
-
(2003)
Hepatology
, vol.38
, pp. 518-526
-
-
Wai, C.T.1
Greenson, J.K.2
Fontana, R.J.3
|